• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞疾病

Eosinophilic disorders.

作者信息

Simon Dagmar, Simon Hans-Uwe

机构信息

Department of Dermatology, University of Bern, Bern, Switzerland.

出版信息

J Allergy Clin Immunol. 2007 Jun;119(6):1291-300; quiz 1301-2. doi: 10.1016/j.jaci.2007.02.010. Epub 2007 Apr 2.

DOI:10.1016/j.jaci.2007.02.010
PMID:17399779
Abstract

Eosinophilic inflammatory responses occur in association with multiple disorders. Although the initial cause and the affected organs vary among the different eosinophilic disorders, there are only 2 major pathways that mediate eosinophilia: (1) cytokine-mediated increased differentiation and survival of eosinophils (extrinsic eosinophilic disorders), and (2) mutation-mediated clonal expansion of eosinophils (intrinsic eosinophilic disorders). Independent from the original trigger, the most common cause of eosinophilia is the increased generation of IL-5-producing T cells. In some cases, tumor cells are the source of eosinophil hematopoietins. The intrinsic eosinophilic disorders are characterized by mutations in pluripotent or multipotent hematopoietic stem cells leading to chronic myeloid leukemias with eosinophils as part of the clone. Here, we propose a new classification of eosinophilic disorders on the basis of these obvious pathogenic differences between the 2 groups of patients. We then discuss many known eosinophilic disorders, which can be further subdivided by differences in T-cell activation mechanisms, origin of the cytokine-producing tumor cell, or potency of the mutated stem cell. Interestingly, many subgroups of patients originally thought to have the idiopathic hypereosinophilic syndrome can be integrated in this classification.

摘要

嗜酸性粒细胞炎症反应与多种疾病相关。尽管不同嗜酸性粒细胞疾病的初始病因和受累器官各不相同,但介导嗜酸性粒细胞增多的主要途径只有两条:(1)细胞因子介导的嗜酸性粒细胞分化增加和存活时间延长(外在性嗜酸性粒细胞疾病),以及(2)突变介导的嗜酸性粒细胞克隆性扩增(内在性嗜酸性粒细胞疾病)。嗜酸性粒细胞增多最常见的原因是产生白细胞介素-5的T细胞生成增加,与最初的触发因素无关。在某些情况下,肿瘤细胞是嗜酸性粒细胞造血因子的来源。内在性嗜酸性粒细胞疾病的特征是多能或多潜能造血干细胞发生突变,导致慢性髓系白血病,嗜酸性粒细胞作为克隆的一部分。在此,我们基于这两组患者之间明显的致病差异,提出了一种嗜酸性粒细胞疾病的新分类方法。然后我们讨论了许多已知的嗜酸性粒细胞疾病,这些疾病可根据T细胞激活机制、产生细胞因子的肿瘤细胞来源或突变干细胞的潜能差异进一步细分。有趣的是,许多最初被认为患有特发性高嗜酸性粒细胞综合征的患者亚组可以纳入这一分类。

相似文献

1
Eosinophilic disorders.嗜酸性粒细胞疾病
J Allergy Clin Immunol. 2007 Jun;119(6):1291-300; quiz 1301-2. doi: 10.1016/j.jaci.2007.02.010. Epub 2007 Apr 2.
2
Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.嗜酸性粒细胞疾病:分子发病机制、新分类及现代治疗
Best Pract Res Clin Haematol. 2006;19(3):535-69. doi: 10.1016/j.beha.2005.07.013.
3
Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.嗜酸性粒细胞白血病和特发性高嗜酸性粒细胞综合征。
Br J Haematol. 1996 Oct;95(1):2-9.
4
T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.人嗜酸性粒细胞生成的T淋巴细胞控制。特发性嗜酸性粒细胞增多综合征的克隆分析。
J Immunol. 1987 Dec 1;139(11):3753-8.
5
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.嗜酸性粒细胞增多症及嗜酸性粒细胞相关疾病的发病机制、分类与治疗
Blood Rev. 2009 Jul;23(4):157-65. doi: 10.1016/j.blre.2009.01.001. Epub 2009 Feb 25.
6
Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.用单克隆抗IL-5抗体SCH55700治疗高嗜酸性粒细胞综合征和嗜酸性粒细胞性胃肠炎后的反弹性嗜酸性粒细胞增多。
J Allergy Clin Immunol. 2004 Dec;114(6):1449-55. doi: 10.1016/j.jaci.2004.08.027.
7
Eosinophilic myeloid disorders.嗜酸性粒细胞髓系疾病。
Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008.
8
Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.嗜酸性粒细胞增多相关肌肉疾病:一项针对主要碱性蛋白在不同临床病理形式中的组织定位的免疫组织学研究。
J Clin Pathol. 2009 May;62(5):442-7. doi: 10.1136/jcp.2008.060616. Epub 2009 Jan 12.
9
[Hypereosinophilia of the blood. II. Classification. Benign essential hypereosinophilia. Eosinophilia caused by systemic eosinophilic hemopathies].[血液嗜酸性粒细胞增多症。II. 分类。良性特发性嗜酸性粒细胞增多症。由系统性嗜酸性粒细胞血液病引起的嗜酸性粒细胞增多症]
Minerva Med. 1985 May 31;76(22-23):1049-53.
10
Classification of eosinophilic gastrointestinal diseases.嗜酸性胃肠道疾病的分类
Best Pract Res Clin Gastroenterol. 2008;22(3):425-40. doi: 10.1016/j.bpg.2007.12.008.

引用本文的文献

1
Innate Immunity and Synovitis: Key Players in Osteoarthritis Progression.先天免疫与滑膜炎:骨关节炎进展的关键因素。
Int J Mol Sci. 2024 Nov 11;25(22):12082. doi: 10.3390/ijms252212082.
2
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).管理嗜酸性粒细胞增多综合征患者:意大利变态反应、哮喘和临床免疫学学会(SIAAIC)的声明。
Cells. 2024 Jul 11;13(14):1180. doi: 10.3390/cells13141180.
3
The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review.
嗜酸性粒细胞增多症及嗜酸性粒细胞疾病的诊断与分类挑战:综述
Cent Eur J Immunol. 2024;49(1):60-69. doi: 10.5114/ceji.2024.136512. Epub 2024 Apr 19.
4
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significance.慢性炎症性呼吸道疾病和慢性鼻窦炎伴鼻息肉中的嗜酸性粒细胞:功能、免疫基础及临床意义
Allergol Select. 2024 Mar 21;8:40-50. doi: 10.5414/ALX02469E. eCollection 2024.
5
Cyba and Nox2 mutant rats show different incidences of eosinophilia in the genetic background- and sex-dependent manner.Cyba 和 Nox2 基因突变大鼠在遗传背景和性别依赖性方面表现出不同的嗜酸性粒细胞增多症发生率。
Exp Anim. 2023 May 17;72(2):233-241. doi: 10.1538/expanim.22-0122. Epub 2022 Nov 29.
6
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.建议的嗜酸粒细胞疾病及相关综合征的改良诊断标准和分类。
Allergy. 2023 Jan;78(1):47-59. doi: 10.1111/all.15544. Epub 2022 Oct 19.
7
Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis disorder and splinter hemorrhages: A case report.表现为嗜酸性粒细胞性胃肠炎和裂片样出血的高嗜酸性粒细胞综合征:一例报告。
World J Gastrointest Pharmacol Ther. 2022 Mar 5;13(2):23-29. doi: 10.4292/wjgpt.v13.i2.23.
8
Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.过敏症争议:生物制剂在嗜酸性疾病中作为一线治疗的潜在作用。
J Allergy Clin Immunol Pract. 2022 May;10(5):1169-1176. doi: 10.1016/j.jaip.2022.01.043. Epub 2022 Feb 12.
9
History of Allergy: Clinical Descriptions, Pathophysiology, and Treatment.过敏史:临床描述、病理生理学和治疗。
Handb Exp Pharmacol. 2022;268:3-19. doi: 10.1007/164_2021_509.
10
Eosinophils in skin diseases.皮肤疾病中的嗜酸性粒细胞。
Semin Immunopathol. 2021 Jun;43(3):393-409. doi: 10.1007/s00281-021-00868-7. Epub 2021 Jun 7.